Loading...
Management of direct factor Xa inhibitor–related major bleeding with prothrombin complex concentrate: a meta-analysis
A targeted antidote for reversal of direct factor Xa (FXa) inhibitors is now available for clinical use in the United States, but it is costly and has limited availability. In a systematic review, we evaluated the safety and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) as an al...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341194/ https://ncbi.nlm.nih.gov/pubmed/30658963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018024133 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|